S-ethyl cysteine and s-propyl cysteine alleviate β-amyloid induced cytotoxicity in nerve growth factor differentiated PC12 cells

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 11, 2010, Pages 7104-7108

  Tsai, Shih Jei ^a,b   Lin, Chia Yu ^c   Mong, Mei Chin ^c   Ho, Mao Wang ^d   Yin, Mei Chin ^c,e  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

A ; Caspase activity; Cytokine; Na+ 'K+ ATPase; S ethyl cysteine; S propyl cysteine

Indexed keywords

AMYLOID BETA PROTEIN; CYSTEINE; DRUG DERIVATIVE; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENT; S ETHYLCYSTEINE; S PROPYLCYSTEINE; S-ETHYLCYSTEINE; S-PROPYLCYSTEINE;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN; CELL SURVIVAL; CYTOLOGY; DNA FRAGMENTATION; DRUG EFFECT; GENETICS; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL; PATHOPHYSIOLOGY; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; CYSTEINE; DNA FRAGMENTATION; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NERVE GROWTH FACTOR; NEURONS; NEUROPROTECTIVE AGENTS; PC12 CELLS; RATS;

EID: 77953175681     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf1009318     Document Type: Article

References (28)

1. Christensen, D. D. Alzheimer's disease: progress in the development of anti-amyloid disease-modifying therapies CNS Spectr. 2007, 12, 113-116
2. Seabrook, G. R.; Ray, W. J.; Shearman, M.; Hutton, M. Beyond amyloid: the next generation of Alzheimer's disease therapeutics Mol. Interventions 2007, 7, 261-270
3. Su, B.; Wang, X.; Nunomura, A.; Moreira, P. I.; Lee, H. G.; Perry, G.; Smith, M. A.; Zhu, X. Oxidative stress signaling in Alzheimer's disease Curr. Alzheimer Res. 2008, 5, 525-532
4. Biswas, S. C.; Shi, Y.; Vonsattel, J. P.; Leung, C. L.; Troy, C. M.; Greene, L. A. Bim is elevated in Alzheimer's disease neurons and is required for beta-amyloid-induced neuronal apoptosis J. Neurosci. 2007, 27, 893-900
5. Vukic, V.; Callaghan, D.; Walker, D.; Lue, L. F.; Liu, Q. Y.; Couraud, P. O.; Romero, I. A.; Weksler, B.; Stanimirovic, D. B.; Zhang, W. Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway Neurobiol. Dis. 2009, 34, 95-106
6. Yamamoto, M.; Kiyota, T.; Horiba, M.; Buescher, J. L.; Walsh, S. M.; Gendelman, H. E.; Ikezu, T. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice Am. J. Pathol. 2007, 170, 680-692
7. Jones, M. G.; Hughes, J.; Tregova, A.; Milne, J.; Tomsett, A. B.; Collin, H. A. Biosynthesis of the flavour precursors of onion and garlic J. Exp. Bot. 2004, 55, 1903-1918
8. Fukushima, S.; Takada, N.; Hori, T.; Wanibuchi, H. Cancer prevention by organosulfur compounds from garlic and onion J. Cell Biochem. 1997, 27, 100-105
9. Chen, C. M.; Yin, M. C.; Hsu, C. C.; Liu, T. C. Anti-oxidative and anti-inflammatory effects of four cysteine-containing agents in striatum of MPTP-treated mice Nutrition 2007, 23, 589-597
10. Chen, C. M.; Yin, M. C. S-allyl cysteine, s-ethyl cysteine and s-propyl cysteine alleviate oxidative stress induced damage within PC12 cells J. Sci. Food Agric. 2008, 88, 2493-2498
11. Rausch, D. M.; Dickens, G.; Doll, S.; Fujita, K.; Koizumi, S.; Rudkin, B. B.; Tocco, M.; Eiden, L. E.; Guroff, G. Differentiation of PC12 cells with v-src: comparison with nerve growth factor J. Neurosci. Res. 1989, 24, 49-58
12. Lipman, T.; Tabakman, R.; Lazarovici, P. Neuroprotective effects of the stable nitroxide compound Tempol on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in the nerve growth factor-differentiated model of pheochromocytoma PC12 cell Eur. J. Pharmacol. 2006, 549, 50-57
13. +-ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress J. Cell Sci. 2003, 116, 2099-2110
14. Ashraf, Q. M.; Mishra, O. P.; Delivoria-Papadopoulos, M. Mechanisms of expression of apoptotic protease activating factor-1 (Apaf-1) in nuclear, mitochondrial and cytosolic fractions of the cerebral cortex of newborn piglets Neurosci. Lett. 2007, 415, 253-258
15. Shimma, N.; Akiyama, N.; Umezawa, M.; Okuma, Y.; Nomura, Y.; Saito, T.; Horie, S.; Murayama, T. Possible role of interleukin-6 in PC12 cell dearth induced by MPP+ and tetrahydroisoquinoline J. Pharmacol. Sci. 2003, 93, 471-477
16. Li, Y.; Liu, L.; Kang, J.; Sheng, J. G.; Barger, S. W.; Mrak, R. E.; Griffin, W. S. Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression J. Neurosci. 2000, 20, 149-155
17. Hung, L. W.; Ciccotosto, G. D.; Giannakis, E.; Tew, D. J.; Perez, K.; Masters, C. L.; Cappai, R.; Wade, J. D.; Barnham, K. J. Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity J. Neurosci. 2008, 28, 11950-11958
18. Sul, D.; Kim, H. S.; Lee, D.; Joo, S. S.; Hwang, K. W.; Park, S. Y. Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation Life Sci. 2009, 84, 257-262
19. 2+-ATPase activities in rat brain synaptosomes J. Physiol. Pharmacol. 2004, 55, 457-465
20. Sharifi, A. M.; Eslami, H.; Larijani, B.; Davoodi, J. Involvement of caspase-8, -9, and -3 in high glucose-induced apoptosis in PC12 cells Neurosci. Lett. 2009, 459, 47-51
21. Marques, C. A.; Keil, U.; Bonert, A.; Steiner, B.; Haass, C.; Muller, W. E.; Eckert, A. Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway J. Biol. Chem. 2003, 278, 28294-28302
22. Ranger, A. M.; Malynn, B. A.; Korsmeyer, S. J. Mouse models of cell death Nat. Genet. 2001, 28, 113-118
23. Zotova, E.; Nicoll, J. A.; Kalaria, R.; Holmes, C.; Boche, D. Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy Alzheimers Res. Ther. 2010, 2, 1-7
24. Genc, S.; Egrilmez, M. Y.; Yaka, E.; Cavdar, Z.; Iyilikci, L.; Yener, G.; Genc, K. TNF-related apoptosis-inducing ligand level in Alzheimer's disease Neurol. Sci. 2009, 30, 263-267
25. Koppel, J.; Bradshaw, H.; Goldberg, T. E.; Khalili, H.; Marambaud, P.; Walker, M. J.; Pazos, M.; Gordon, M. L.; Christen, E.; Davies, P. Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study Lipids Health. Dis. 2009, 8, 2-7
26. Freund-Levi, Y.; Hjorth, E.; Lindberg, C.; Cederholm, T.; Faxen-Irving, G.; Vedin, I.; Palmblad, J.; Wahlund, L. O.; Schultzberg, M.; Basun, H.; Eriksdotter-Jönhagen, M. Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study Dementia Geriatr. Cognit. Disord. 2009, 27, 481-490
27. Jana, M.; Palencia, C. A.; Pahan, K. Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease J. Immunol. 2008, 181, 7254-7262
28. Krest, I.; Glodek, J.; Keusgen, M. Cysteine sulfoxides and alliinase activity of some Allium species J. Agric. Food Chem. 2000, 48, 3753-3760